Skip to main content
. 2024 Nov 1;11:59. doi: 10.1186/s40621-024-00547-9

Table 1.

Characteristics of exposures involving gabapentin or pregabalin as the primary substance reported to the national poison data system by age group, 2012–2022

Characteristics Age group
≤ 5 years
n (%)a
6–19 years
n (%)a
20–29 years
n (%)a
30–39 years
n (%)a
40–49 years
n (%)a
50–59 years
n (%)a
≥ 60 years
n (%)a
Unknown Total
n (%)a
Sex
Male 7,935 (51.1) 3,747 (36.9) 6,860 (44.0) 8,332 (42.2) 7,246 (38.1) 7,004 (38.7) 7,293 (35.3) 1,849 50,266 (40.6)
Female 7,599 (48.9) 6,398 (63.1) 8,722 (56.0) 11,403 (57.8) 11,762 (61.9) 11,094 (61.3) 13,375 (64.7) 3,098 73,451 (59.4)
Unknown 45 11 16 16 14 8 20 314 444
Type of exposure
Single-substance 13,498 (86.6) 6,851 (67.5) 8,838 (56.7) 10,733 (54.3) 10,052 (52.8) 10,085 (55.7) 14,049 (67.9) 4,122 78,228 (62.9)
Multiple-substance 2,081 (13.4) 3,305 (32.5) 6,760 (43.4) 9,018 (45.7) 8,970 (47.2) 8,021 (44.3) 6,639 (32.1) 1,139 45,933 (37.1)
Reason for exposure
Unintentional 15,524 (99.8) 2,549 (25.2) 1,879 (12.2) 2,741 (14.1) 3,499 (18.7) 5,185 (29.2) 13,044 (64.3) 2,552 46,973 (38.5)
 Unintentional–general 14,946 (96.1) 554 (5.5) 328 (2.1) 385 (2.0) 427 (2.3) 450 (2.5) 865 (4.3) 342 18,297 (15.0)
 Unintentional–therapeutic error 548 (3.5) 1,917 (19.0) 1,447 (9.4) 2,193 (11.3) 2,939 (15.7) 4,580 (25.8) 11,947 (58.9) 2,139 27,710 (22.7)
 Unintentional–otherb 27 (0.2) 64 (0.6) 88 (0.6) 115 (0.6) 99 (0.5) 116 (0.7) 185 (0.9) 55 749 (0.6)
 Unintentional–unknown 3 (0.0) 14 (0.1) 16 (0.1) 48 (0.2) 34 (0.2) 39 (0.2) 47 (0.2) 16 217 (0.2)
Intentional 2 (0.0) 7,430 (73.9) 13,143 (85.7) 16,263 (83.9) 14,730 (78.9) 11,920 (67.1) 6,020 (29.7) 1,943 71,451 (58.5)
 Intentional–suspected suicide 2 (0.0) 5,854 (58.2) 9,867 (64.3) 12,522 (64.6) 11,942 (63.9) 9,527 (53.7) 4,240 (20.9) 1,251 55,205 (45.2)
 Intentional–misuse 0 (0.0) 418 (4.2) 1,128 (7.4) 1,412 (7.3) 1,191 (6.4) 1,140 (6.4) 1,120 (5.5) 227 6,636 (5.4)
 Intentional–abuse 0 (0.0) 844 (8.4) 1,495 (9.7) 1,459 (7.5) 855 (4.6) 576 (3.2) 276 (1.4) 195 5,700 (4.7)
 Intentional–unknown 0 (0.0) 314 (3.1) 653 (4.3) 870 (4.5) 742 (4.0) 677 (3.8) 384 (1.9) 270 3,910 (3.2)
Otherc 22 (0.1) 86 (0.9) 320 (2.1) 388 (2.0) 445 (2.4) 627 (3.5) 1,220 (6.0) 584 3,692 (3.0)
Unknown 31 91 256 359 348 374 404 182 2,045
Management site
Managed on site (not in a healthcare facility) 10,414 (67.4) 2,107 (20.9) 1,724 (11.1) 2,361 (12.0) 3,049 (16.1) 4,542 (25.2) 11,622 (56.7) 2,787 38,606 (31.3)
Individual already in (en route to) a healthcare facility 3,475 (22.5) 6,979 (69.1) 12,325 (79.4) 15,771 (80.2) 14,641 (77.3) 12,360 (68.6) 7,474 (36.5) 688 73,713 (60.0)
Individual referred by poison center to a healthcare facility 1,509 (9.8) 915 (9.1) 1,371 (8.8) 1,407 (7.2) 1,145 (6.0) 1,002 (5.6) 1,152 (5.6) 1,477 9,978 (8.1)
Other 56 (0.4) 93 (0.9) 108 (0.7) 122 (0.6) 109 (0.6) 126 (0.7) 251 (1.2) 108 973 (0.8)
Unknown 125 62 70 90 78 76 189 201 891
Highest level of health care received
No healthcare facility treatment receivedd 10,470 (69.9) 2,200 (23.0) 1,832 (12.8) 2,483 (13.5) 3,158 (17.6) 4,668 (27.1) 11,873 (60.1) 2,895 39,579 (34.0)
Treated/evaluated and released 3,950 (26.4) 3,155 (33.0) 4,795 (33.5) 5,450 (29.6) 4,679 (26.0) 3,866 (22.5) 2,894 (14.7) 257 29,046 (25.1)
Admitted 352 (2.4) 4,037 (39.3) 7,349 (51.3) 10,092 (55.0) 9,830 (54.8) 8,431 (49.0) 4,655 (23.6) 221 44,967 (39.0)
 Admitted to a critical care unit 144 (1.0) 724 (7.6) 1,949 (13.6) 3,136 (17.1) 3,178 (17.7) 2,750 (16.0) 1,546 (7.8) 60 13,487 (11.7)
 Admitted to a non-critical care unit 204 (1.4) 763 (8.0) 1,466 (10.2) 2,218 (12.1) 2,132 (11.9) 2,169 (12.6) 1,709 (8.7) 51 10,712 (9.3)
 Admitted to a psychiatric facility 4 (0.0) 2,550 (26.7) 3,934 (27.5) 4,738 (25.8) 4,520 (25.2) 3,512 (20.4) 1,400 (7.1) 110 20,768 (18.0)
Refused referral/did not arrive at healthcare facility 204 (1.4) 162 (1.7) 353 (2.5) 363 (2.0) 297 (1.7) 252 (1.5) 326 (1.7) 420 2,377 (2.0)
Unknowne 603 602 1,269 1,363 1,058 889 940 1,468 8,192
Medical outcome
No effect 7,410 (49.6) 2,675 (27.7) 3,217 (22.2) 3,731 (20.1) 3,502 (19.4) 3,139 (18.1) 3,462 (17.4) 421 27,557 (23.6)
Minor effect 1,129 (7.6) 3,389 (35.1) 5,331 (36.8) 6,473 (34.9) 6,065 (33.6) 5,215 (30.1) 3,867 (19.4) 468 31,937 (27.4)
Serious medical outcome 179 (1.2) 1,729 (17.9) 4,010 (27.6) 5,883 (31.7) 5,583 (30.9) 4,935 (28.4) 3,147 (15.8) 193 25,659 (22.1)
 Moderate effect 167 (1.1) 1,536 (15.9) 3,373 (23.3) 4,891 (26.4) 4,601 (25.5) 4,065 (23.4) 2,589 (13.0) 167 21,389 (18.3)
 Major effect 12 (0.1) 191 (2.0) 630 (4.3) 972 (5.2) 964 (5.3) 845 (4.9) 537 (2.7) 23 4,174 (3.6)
 Death 0 (0.0) 2 (0.0) 7 (0.0) 20 (0.1) 18 (0.1) 25 (0.1) 21 (0.1) 3 96 (0.1)
Not followedf 6,219 (42.1) 1,851 (19.4) 1,930 (13.8) 2,469 (12.9) 2,905 (16.1) 4,050 (23.7) 9,417 (47.2) 2,579 31,420 (27.0)
Unknowng 642 512 1,110 1,195 967 767 795 1,600 7,588
Total (row %) 15,579 (12.6) 10,156 (8.2) 15,598 (12.6) 19,751 (16.0) 19,022 (15.4) 18,106 (14.7) 20,688 (16.8) 5,261 124,161 (100.0)

aColumn percentages may not add to 100.0% due to rounding error

b Includes unintentional-environmental, unintentional-occupational, and unintentional-misuse

cIncludes other-contamination/tampering, other-malicious, other-withdrawal, adverse reaction-drug or other

d Includes cases for which management site was recorded “managed on site (not in a healthcare facility)” or “other”

e Includes patient lost to follow-up/ left against medical advice/unknown

f Includes “not followed (minimal clinical effects possible)” and “not followed (judged as a non-toxic exposure)”

g Includes “unable to follow (judged as a potentially toxic exposure)”